Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227722 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Actual shortage | 2024-05-10 | 2024-05-10 | 227728 |
| APO-COLESEVELAM | 625MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216646 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2024-02-09 | 2024-05-10 | 219159 |
| APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2024-04-05 | 2024-05-10 | 224598 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225767 |
| APO-TICAGRELOR | 90MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225026 |
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227091 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227076 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2024-04-19 | 2024-05-22 | 225802 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 224990 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-03 | 2024-05-24 | 227088 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
| BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
| IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |